U.S. task force does not recommend treadmill exercise testing or resting electrocardiograms as screening tests for asymptomatic, low-risk adults
New guidelines from the U.S. Preventive Services
Task Force do not recommend use of treadmill exercise testing, resting
electrocardiograms, or electron beam computerized tomography to
screen for heart disease in asymptomatic, low-risk adults, according
to an article in the February 17th issue of Annals of Internal Medicine.
For adults at higher risk for heart disease, the Task Force found
insufficient evidence for or against using these three tests for
screening.
An estimated 22 million Americans have heart
disease, and more than 700,000 die from it each year. Heart disease
is the leading killer of both men and women and is estimated to
cost more than $350 billion annually in medical care, time lost
from work, and other expenses.
Men under age 50 years and women under age
60 years who have normal blood pressure and cholesterol levels,
do not smoke, and do not have diabetes are considered at low risk
of heart disease. A simple calculator to estimate risk of heart
disease can be found at http://hin.nhlbi.nih.gov/atpiii/calculator.asp?usertype=pub.
The Task Force recommends screening for many
of the risks for heart disease, such as hypertension, obesity, diabetes,
and high cholesterol levels. Although treadmill testing, electrocardiography,
and electron beam computed tomography could identify persons at
higher risk of heart disease, no studies to date have examined whether
or not using these tests to screen adults improves health outcomes.
Furthermore, the Task Force concluded that using the three technologies
to screen for heart disease in low-risk adults could cause more
harm than good because of the frequency of false-positive and false-negative
results.
The Task Force said that the evidence is
inadequate to determine how test results would change the course
of treating patients and noted concern that potential harms, such
as false-positive findings, unnecessary invasive procedures, and
over-treatment could outweigh any benefit of the tests in lower
risk persons.
"These recommendations can help clinicians
and their patients make more informed decisions about use of these
tests to screen for heart disease and may help guide employers and
insurers as well," said Task Force chair, Ned Calonge, MD.
"The most important thing individuals at low risk can do is
to work with their clinician to monitor their blood pressure, cholesterol,
and weight, and to be physically active."
|